Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers-Reference-Cited by-同舟云学术

Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers

Published:2018-08-29 Issue:1 Volume:4 Page:
ISSN:2057-3804
Container-title:Cardio-Oncology
language:en
Short-container-title:Cardio-Oncology

Author:

Poklepovic Andrew^ORCID,Qu Yuesheng,Dickinson Molly,Kontos Michael C.,Kmieciak Maciej,Schultz Elizabeth,Bandopadhyay Dipankar,Deng Xiaoyan,Kukreja Rakesh C.

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Materials Science (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s40959-018-0033-2.pdf

Reference22 articles.

1. Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med. 2008;358(16):1663–71.

2. Fernandez HF, Sun Z, Yao X, Litzow MR, Luger SM, Paietta EM, Racevskis J, Dewald GW, Ketterling RP, Bennett JM, et al. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med. 2009;361(13):1249–59.

3. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235–42.

4. FDA Statement on Dexrazoxane. In.: U.S. Food and Drug Administration. Drug Saf and Availability; 2011.

5. Tap WD, Jones RL, Van Tine BA, Chmielowski B, Elias AD, Adkins D, Agulnik M, Cooney MM, Livingston MB, Pennock G, et al. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial. Lancet. 2016;388(10043):488–97.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Multifaceted Potential of Sildenafil in Medicine;Medicina;2023-12-17

2. Androgen-deprivation therapy with leuprolide increases abdominal adiposity without causing cardiac dysfunction in middle-aged male mice: effect of sildenafil;American Journal of Physiology-Regulatory, Integrative and Comparative Physiology;2023-04-01

3. Beyond Erectile Dysfunction: cGMP-Specific Phosphodiesterase 5 Inhibitors for Other Clinical Disorders;Annual Review of Pharmacology and Toxicology;2023-01-20

4. A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma;Neuro-Oncology Advances;2023-01-01

5. Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity;Frontiers in Cardiovascular Medicine;2022-02-25